Vera Therapeutics Inc (VERA)
43.44
-0.06
(-0.14%)
USD |
NASDAQ |
May 03, 16:00
43.45
+0.01
(+0.02%)
After-Hours: 20:00
Vera Therapeutics Free Cash Flow: -92.18M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -92.18M |
| September 30, 2023 | -88.20M |
| June 30, 2023 | -83.65M |
| March 31, 2023 | -84.91M |
| December 31, 2022 | -67.66M |
| September 30, 2022 | -52.93M |
| June 30, 2022 | -39.96M |
| Date | Value |
|---|---|
| March 31, 2022 | -28.59M |
| December 31, 2021 | -23.71M |
| September 30, 2021 | -44.65M |
| June 30, 2021 | -41.62M |
| March 31, 2021 | -36.67M |
| December 31, 2020 | -34.91M |
Free Cash Flow Range, Past 5 Years
-92.18M
Minimum
Dec 2023
-23.71M
Maximum
Dec 2021
-55.36M
Average
-44.65M
Median
Sep 2021
Free Cash Flow Benchmarks
| Vertex Pharmaceuticals Inc | 3.279B |
| Alpine Immune Sciences Inc | -79.50M |
| Fate Therapeutics Inc | -138.42M |
| Mersana Therapeutics Inc | -171.05M |
| Equillium Inc | -21.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -25.14M |
| Cash from Investing (Quarterly) | 18.56M |
| Cash from Financing (Quarterly) | 24.83M |
| Free Cash Flow Per Share (Quarterly) | -0.5656 |
| Free Cash Flow Yield | -4.97% |